Paolini John F. sold KNSA
October 30, 2026 · Form 4 insider transaction
Paolini John F. sold 41,789 shares of Kiniksa Pharmaceuticals International, plc at $92.02 per share, a transaction worth $3.85M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on July 29, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $91.3575 and $92.355. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.